Filters close
Newswise: Answers from an Expert: Sarcoma, the Forgotten Cancer
Released: 5-Jul-2022 8:05 AM EDT
Answers from an Expert: Sarcoma, the Forgotten Cancer
Rutgers Cancer Institute of New Jersey

Adam C. Berger, MD, FACS, chief of Melanoma and Soft Tissue Surgical Oncology and associate director for Shared Resources at Rutgers Cancer Institute of New Jersey addresses common questions about sarcoma during sarcoma awareness month.

Newswise: Exploring Radiation-Induced Toxicities from a Nursing Perspective
Released: 22-Jun-2022 11:30 AM EDT
Exploring Radiation-Induced Toxicities from a Nursing Perspective
Rutgers Cancer Institute of New Jersey

Dorothy N. Pierce, DNP, NP-C, CRN, CBCN, a nurse practitioner in the Department of Radiation Oncology at Rutgers Cancer Institute of New Jersey, highlights the role of advanced practice nurses (APNs) in providing supportive care for patients experiencing radiation proctitis.

Newswise: Rutgers Cancer Institute of New Jersey and its top research leader Dr. Eileen White selected to lead global Cancer Grand Challenges team taking on cancer cachexia
14-Jun-2022 8:40 AM EDT
Rutgers Cancer Institute of New Jersey and its top research leader Dr. Eileen White selected to lead global Cancer Grand Challenges team taking on cancer cachexia
Rutgers Cancer Institute of New Jersey

A world-class team of researchers assembled and led by Rutgers Cancer Institute of New Jersey and its Deputy Director and Chief Scientific Officer Eileen White, PhD, has been awarded a $25 million Cancer Grand Challenges grant to tackle the condition of cancer cachexia.

Newswise: Addressing the Unique Needs of LGBTQ+ Cancer Patients
Released: 6-Jun-2022 4:05 PM EDT
Addressing the Unique Needs of LGBTQ+ Cancer Patients
Rutgers Cancer Institute of New Jersey

June marks Pride Month when we honor the diversity, strength, and resilience of the LGBTQ+ community. We must also call to attention the healthcare challenges and barriers faced by this community.

Newswise: Radiation Therapy as Effective as Surgery for Prostate Cancer
Released: 6-Jun-2022 4:05 PM EDT
Radiation Therapy as Effective as Surgery for Prostate Cancer
Rutgers Cancer Institute of New Jersey

Radiation is an effective treatment for prostate cancer. Ronald D. Ennis, MD,Professor and Vice Chair of Network Integration and Quality, Department of Radiation Oncology at Rutgers Cancer Institute, along with Lara Hathout, MD, FRCPC, radiation oncologist and director of Brachytherapy at Rutgers Cancer Institute and associate Professor of radiation oncology at Rutgers Robert Wood Johnson Medical School share more

Released: 27-May-2022 11:05 AM EDT
Rutgers Cancer Institute of New Jersey RWJBarnabas Health Facilities Receive First Regional Accreditation by American College of Radiology
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey Department of Radiation Oncology at Robert Wood Johnson University Hospital New Brunswick, Somerset and Hamilton, all RWJBarnabas Health facilities, received their first regional accreditation by the American College of Radiology (ACR).

Newswise: Exploring Cancer and Health Data on Asian American and Pacific Islanders
Released: 19-May-2022 10:05 AM EDT
Exploring Cancer and Health Data on Asian American and Pacific Islanders
Rutgers Cancer Institute of New Jersey

Cancer health disparities are often identified from population-based surveillance data routinely captured by statewide cancer registries. Antoinette Stroup, PhD, of Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute – Designated Comprehensive Cancer Center together with RWJBarnabas Health and Rutgers School of Public Health is the director of the New Jersey State Cancer Registry (NJSCR), explores cancer and health data on the Asian American and Pacific Islander population.

Newswise: Colon Microbes Provide Clues to Favorable Treatment Options in a Subset of Colon Cancer Patients
Released: 19-May-2022 10:05 AM EDT
Colon Microbes Provide Clues to Favorable Treatment Options in a Subset of Colon Cancer Patients
Rutgers Cancer Institute of New Jersey

Investigators from Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute- Designated Comprehensive Cancer Center, led a collaborative study to examine the patterns of druggable oncogenic fusions in colon cancer specimens including microsatellite-stable and unstable (MSI) tumors.

Newswise: Honoring Rutgers Cancer Institute of New Jersey Nurses
Released: 11-May-2022 8:05 AM EDT
Honoring Rutgers Cancer Institute of New Jersey Nurses
Rutgers Cancer Institute of New Jersey

Two nurses are named recipients of Rutgers Cancer Institute’s ‘Oncology Nursing Excellence Awards’ during Nurses Week each year. This year’s award recipients were named during the annual Elizabeth Gibby Osborne Lecture today.

Newswise: Extensive Research Underway to Address Cancer Disparities
Released: 2-May-2022 12:00 PM EDT
Extensive Research Underway to Address Cancer Disparities
Rutgers Cancer Institute of New Jersey

To highlight the importance of lifesaving cancer research, National Cancer Research Month, led by the American Association for Cancer Research (AACR), is recognized during May. Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, has curated a selection of ongoing research focusing on cancer disparities which features members from the Cancer Health Equity Center of Excellence.

Newswise: 5 Tips to Boost Bladder Health
Released: 2-May-2022 12:00 PM EDT
5 Tips to Boost Bladder Health
Rutgers Cancer Institute of New Jersey

Saum Ghodoussipour, MD, urologic oncologist and director of the Bladder and Urothelial Cancer Program at Rutgers Cancer Institute and assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more on bladder health.

Newswise: Noninvasive Brain Tumor Treatment Allows Physicians to treat tumors with Pinpoint Accuracy
Released: 2-May-2022 12:00 PM EDT
Noninvasive Brain Tumor Treatment Allows Physicians to treat tumors with Pinpoint Accuracy
Rutgers Cancer Institute of New Jersey

Joseph P. Weiner, MD, radiation oncologist at Rutgers Cancer Institute and assistant professor of radiation oncology at Rutgers Robert Wood Johnson Medical School, who specializes in malignant and benign cancers of the brain and spine shares more about Gamma knife, a non-surgical treatment option that uses high doses of precisely focused radiation beams to destroy cancer cells and non-cancerous tumors.

Newswise: Exploring Sun Protection Behaviors among U.S. Hispanic Outdoor Workers
Released: 2-May-2022 8:00 AM EDT
Exploring Sun Protection Behaviors among U.S. Hispanic Outdoor Workers
Rutgers Cancer Institute of New Jersey

Carolyn J. Heckman, PhD, co-leader of the Cancer Prevention and Control Program at Rutgers Cancer Institute and an associate professor of medicine at Rutgers Robert Wood Johnson Medical School, is corresponding author and shares more on unburns and sun protection behaviors among male Hispanic outdoor day laborers in the Northeast U.S.

Newswise: How Common is Skin Cancer? And More Questions You’re Afraid to Ask
Released: 2-May-2022 8:00 AM EDT
How Common is Skin Cancer? And More Questions You’re Afraid to Ask
Rutgers Cancer Institute of New Jersey

Sarah Weiss, MD, medical oncologist at Rutgers Cancer Institute of New Jersey and associate professor of medicine at Rutgers Robert Wood Johnson Medical School, answers questions about skin cancer and sun protection that you may be wondering

Newswise: Rutgers Cancer Institute of New Jersey Nurses to Share Knowledge and Best Practices during 47th Annual Oncology Nursing Society Congress
Released: 26-Apr-2022 1:05 PM EDT
Rutgers Cancer Institute of New Jersey Nurses to Share Knowledge and Best Practices during 47th Annual Oncology Nursing Society Congress
Rutgers Cancer Institute of New Jersey

Oncology Nurses from Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health will be presenting at the Oncology Nursing Society’s (ONS) 47th Annual Congress being held April 27 to May 1 in Anaheim, California.

Newswise: American Cancer Society Grants Help Cancer Patients Overcome Transportation Barriers
Released: 25-Apr-2022 7:30 AM EDT
American Cancer Society Grants Help Cancer Patients Overcome Transportation Barriers
Rutgers Cancer Institute of New Jersey

The American Cancer Society has awarded Rutgers Cancer Institute $60,000 in patient transportation and lodging grants, which will help alleviate the financial burden of transportation and lodging costs for cancer patients.

Released: 21-Apr-2022 11:10 AM EDT
New Chief of Bone Marrow Transplant and Cellular Therapies Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Ira Braunschweig, MD, as chief, Section of Transplant and Cell Therapy at Rutgers Cancer Institute, chief of the Transplant and Cell Therapy Service of the RWJBarnabas Health Oncology Service Line, and director for Cell Therapy and Bone Marrow Transplantation at Robert Wood Johnson University Hospital, an RWJBarnabas facility.

Newswise: $3.5 Million NIH Grant to Rutgers Cancer Institute of New Jersey will Support a new ‘Lens’ in Lung Cancer Screening
Released: 14-Apr-2022 7:05 AM EDT
$3.5 Million NIH Grant to Rutgers Cancer Institute of New Jersey will Support a new ‘Lens’ in Lung Cancer Screening
Rutgers Cancer Institute of New Jersey

With the aid of a $3.5 million National Institutes of Health grant (R01HL158850), investigators from Rutgers Cancer Institute of New Jersey – the state’s only National Cancer Institute-designated Comprehensive Cancer Center – along with Holden Cancer Center at the University of Iowa, and the University of Texas MD Anderson Cancer Center, are collaborating on a project to address lung cancer screening disparities among individuals with a history of heavy smoking.

Newswise: $3M Grant Supports Expansion of Digital Intervention for Skin Self Examination among Skin Cancer Survivors
Released: 5-Apr-2022 1:35 PM EDT
$3M Grant Supports Expansion of Digital Intervention for Skin Self Examination among Skin Cancer Survivors
Rutgers Cancer Institute of New Jersey

With the aid of a $3 million National Cancer Institute grant (R01CA2645-01), Rutgers Cancer Institute of New Jersey researchers aim to enhance the effectiveness of a digital intervention that supports skin self-examination for survivors of melanoma, the deadliest form of skin cancer.

Newswise: Testicular Cancer: It’s Time to Talk About it
Released: 4-Apr-2022 10:05 AM EDT
Testicular Cancer: It’s Time to Talk About it
Rutgers Cancer Institute of New Jersey

Young men should become familiar with the symptoms related to testicular cancer and understand how they can play a role in its detection. Rutgers Cancer Institute of New Jersey expert explains.

Newswise: How to Access Cancer Education Resources
Released: 4-Apr-2022 10:05 AM EDT
How to Access Cancer Education Resources
Rutgers Cancer Institute of New Jersey

In the fight against cancer, knowledge is power. Rutgers Cancer Institute of New Jersey's Resource and Learning Center provides patients and families with important educational information.

Newswise: Pet Companionship during the Cancer Journey brings Comfort to the Patient Experience
Released: 4-Apr-2022 10:05 AM EDT
Pet Companionship during the Cancer Journey brings Comfort to the Patient Experience
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey offer forms of pet therapy for cancer patients. Diane L. Haley, MSW, LCSW, OSW-C, director of Patient Experience at Rutgers Cancer Institute of New Jersey shares more about providing patient-centered care through interaction with furry friends.

Newswise: Minority Representation in Clinical Trials is Critical
Released: 4-Apr-2022 9:00 AM EDT
Minority Representation in Clinical Trials is Critical
Rutgers Cancer Institute of New Jersey

Addressing disparities in cancer care, including access to and participation in clinical trials, has long been a priority for Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health. Sanjay Goel, MD, MS, director of the Phase I/Investigational Therapeutics Program at Rutgers Cancer Institute shares more.

Newswise: $3.5 Million NIH Grant will Help Harness Worldwide Big Data to Enhance Decision Support in Hodgkin Lymphoma
Released: 15-Mar-2022 1:00 PM EDT
$3.5 Million NIH Grant will Help Harness Worldwide Big Data to Enhance Decision Support in Hodgkin Lymphoma
Rutgers Cancer Institute of New Jersey

With the aid of a recently awarded $3.5 million, five-year National Cancer Institute grant (R01CA262265), Rutgers Cancer Institute of New Jersey, New Jersey’s only NCI-designated Comprehensive Cancer Center, and Tufts Medical Center in Boston are collaborating on groundbreaking work that is unifying global multi-source big data in order to enhance clinical decision support for improved acute and long-term outcomes for Hodgkin lymphoma patients around the world.

Newswise: What you need to know about Kidney Cancer
Released: 3-Mar-2022 10:05 AM EST
What you need to know about Kidney Cancer
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute expert shares what you need to know about kidney cancer.

Newswise: Importance of Good Nutrition in Children and Young People with Cancer
Released: 2-Mar-2022 2:45 PM EST
Importance of Good Nutrition in Children and Young People with Cancer
Rutgers Cancer Institute of New Jersey

Eating well during cancer treatment is important for a child or young adult as this helps them to cope better with their cancer treatment, fight infection and repair tissues damaged by therapies such as chemotherapy or radiation therapy.

Newswise: Food for Thought: Nutrition and Cancer
Released: 2-Mar-2022 2:35 PM EST
Food for Thought: Nutrition and Cancer
Rutgers Cancer Institute of New Jersey

Good nutrition is an important part of overall health, whether you’re a cancer patient, survivor, caregiver, or loved one, and practicing healthy eating has been shown to help prevent cancer and cancer recurrence.

Newswise: Pediatric Oncology Social Workers: Supporting Children and Families during the Cancer Journey
Released: 2-Mar-2022 1:55 PM EST
Pediatric Oncology Social Workers: Supporting Children and Families during the Cancer Journey
Rutgers Cancer Institute of New Jersey

Susan Stephens, MSW, LCSW, ACSW, social worker at Rutgers Cancer Institute of New Jersey shares more about providing care to pediatric patients and families.

Newswise: Growing Together: The Role of Social Workers in Cancer Care
Released: 2-Mar-2022 1:40 PM EST
Growing Together: The Role of Social Workers in Cancer Care
Rutgers Cancer Institute of New Jersey

In honor of Social Work Month, Joan Hogan, MSW, LCSW, OSW-C, manager of social work services at Rutgers Cancer Institute

Newswise: Finding Resources for Colorectal Cancer Screening
Released: 1-Mar-2022 11:40 AM EST
Finding Resources for Colorectal Cancer Screening
Rutgers Cancer Institute of New Jersey

We know that colorectal cancer screening and early detection and prevention can save lives. Anita Kinney, PhD, shares what resources are available for colorectal cancer screening and how to learn more about them.

Newswise: Exploring Racial and Ethnic Disparities in Colorectal Cancer Screening
Released: 1-Mar-2022 11:30 AM EST
Exploring Racial and Ethnic Disparities in Colorectal Cancer Screening
Rutgers Cancer Institute of New Jersey

Significant disparities persist among some racial and ethnic groups in regards to screening for colorectal cancer. Rutgers Cancer Institute researcher Denalee O'Malley, PhD, focuses her research on this topic. She shares more.

Newswise: Why is Colorectal Cancer on the Rise in Younger People?
Released: 1-Mar-2022 11:20 AM EST
Why is Colorectal Cancer on the Rise in Younger People?
Rutgers Cancer Institute of New Jersey

Colorectal cancer has become prevalent among individuals younger than the age of 50 in recent years. Dr. Patrick Boland at Rutgers Cancer Institute shares what we know about this trend.

Newswise: 45 is the New 50 for Colorectal Cancer Screening
Released: 1-Mar-2022 11:15 AM EST
45 is the New 50 for Colorectal Cancer Screening
Rutgers Cancer Institute of New Jersey

The U.S. Preventative Services Task Force (USPSTF) recommends that people begin colorectal cancer screening at age 45, rather than 50, which was the previous recommendation.

Newswise: Multiple Myeloma: More Common than you think
Released: 1-Mar-2022 11:10 AM EST
Multiple Myeloma: More Common than you think
Rutgers Cancer Institute of New Jersey

Dr. Masi Shah of Rutgers Cancer Institute in partnership with RWJBarnabas Heath shares about Multiple Myeloma, a life changing disease with treatments to help control the disease.

Newswise: Answers from an Expert: Gallbladder and Bile Duct Cancer
Released: 7-Feb-2022 12:10 PM EST
Answers from an Expert: Gallbladder and Bile Duct Cancer
Rutgers Cancer Institute of New Jersey

Miral Sadaria Grandhi, MD, surgical oncologist in the Liver Cancer and Bile Duct Cancer Program at Rutgers Cancer Institute of New Jersey and assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more about gallbladder and bile duct cancer.

Newswise: Parents of Children with Cancer May Need Psychological Support as well as their Child
Released: 3-Feb-2022 11:55 AM EST
Parents of Children with Cancer May Need Psychological Support as well as their Child
Rutgers Cancer Institute of New Jersey

Parents of children with cancer experience stress as they navigate and manage their child’s illness. Karen Long-Traynor, PhD, clinical psychologist in the Pediatric Hematology/Oncology Program at Rutgers Cancer Institute of New Jersey whose current research focuses on psychological support for parents during their child’s treatment and through survivorship, shares more on the impact of childhood cancer on parents and ways to cope.

Newswise: Cancer Prevention: Working to Reduce Disparities
Released: 3-Feb-2022 11:55 AM EST
Cancer Prevention: Working to Reduce Disparities
Rutgers Cancer Institute of New Jersey

One of the primary modes of cancer prevention and early detection in the United States is the widespread practice of screening. However, not all individuals have access to quality cancer screenings or cancer education, which creates significant disparities in cancer outcomes.

Newswise: New Jersey’s Only NCI-designated Comprehensive Cancer Center Names Director for Phase I Clinical Trials and Investigational Therapeutics
Released: 1-Feb-2022 8:05 AM EST
New Jersey’s Only NCI-designated Comprehensive Cancer Center Names Director for Phase I Clinical Trials and Investigational Therapeutics
Rutgers Cancer Institute of New Jersey

Sanjay Goel, MD, MS has been named director of Rutgers Cancer Institute of New Jersey's Phase I/Investigational Therapeutics Program, a multidisciplinary scientific group designed to develop new methods for the treatment of cancer in collaboration with colleagues across the RWJBarnabas Health system.

Newswise: Lung Cancer in Never-Smokers: learn more, protect yourself
Released: 3-Jan-2022 2:05 PM EST
Lung Cancer in Never-Smokers: learn more, protect yourself
Rutgers Cancer Institute of New Jersey

Lung cancer is one of the most common cancers in the world and is a leading cause of cancer-related death in men and women in the United States according to the American Cancer Society. Although cigarette smoking is the main cause of lung cancer and quitting would prevent a large number of lung cancer cases, it wouldn't prevent all of them.

Newswise: Maintaining Thyroid Health
Released: 3-Jan-2022 2:05 PM EST
Maintaining Thyroid Health
Rutgers Cancer Institute of New Jersey

The thyroid plays a large role in your overall health. While there is no known way to prevent thyroid cancer, some things that may help to maintain thyroid health are the lifestyle choices you make. Rutgers Cancer Institute of New Jersey experts share more.

Newswise: Smoking and Cancer: It’s Never too Late to Quit
Released: 3-Jan-2022 1:05 PM EST
Smoking and Cancer: It’s Never too Late to Quit
Rutgers Cancer Institute of New Jersey

Despite a cancer diagnosis and/or cancer treatment, there are smokers who continue with the difficult addiction. As the state’s only National Cancer Institute- designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey now offers a new program, part of the National Cancer Institute’s Moonshot Program, designed to integrate tobacco treatment into the patient-care workflow, to provide state-of-the-art tobacco treatment and cessation support to all patients at no cost.

Newswise: Cervical Cancer can be Prevented
Released: 3-Jan-2022 10:55 AM EST
Cervical Cancer can be Prevented
Rutgers Cancer Institute of New Jersey

Cervical cancer is the only gynecologic cancer that can be prevented—and there are numerous tools to promote prevention including vaccines and tested strategies. James K. Aikins, Jr., MD, FACOG, FACS, chief of Gynecologic Oncology at Rutgers Cancer Institute of New Jersey and associate professor of Obstetrics, Gynecology and Reproductive Sciences at Rutgers Robert Wood Johnson Medical School shares more information about cervical cancer prevention through HPV vaccination, routine PAP tests and lifestyle choices.

Newswise: Examining the Development of T-cell Acute Lymphoblastic Leukemia
10-Dec-2021 12:05 PM EST
Examining the Development of T-cell Acute Lymphoblastic Leukemia
Rutgers Cancer Institute of New Jersey

Researchers from Rutgers Cancer Institute of New Jersey, the state’s only NCI-designated Comprehensive Cancer Center, examined the effects of SIRT1, an enzyme located primarily in the cell nucleus that contributes to cellular regulation on the transformation of T-cells.

Newswise: Exploring New Cancer Therapies that use a Patient’s Immune System to Fight Tumors
Released: 9-Dec-2021 11:40 AM EST
Exploring New Cancer Therapies that use a Patient’s Immune System to Fight Tumors
Rutgers Cancer Institute of New Jersey

Research underway at Rutgers Cancer Institute of New Jersey will contribute to the development of new cancer treatments that are based on the administration of cancer-fighting immune cells to patients.

Newswise: 3D Information and Biomedicine: How Artificial Intelligence/Machine Intelligence will contribute to Cancer Patient Care and Vaccine Design
Released: 7-Dec-2021 12:35 PM EST
3D Information and Biomedicine: How Artificial Intelligence/Machine Intelligence will contribute to Cancer Patient Care and Vaccine Design
Rutgers Cancer Institute of New Jersey

Investigators at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS) explored how Artificial Intelligence/Machine Learning will complement existing approaches focused on genome-protein sequence information, including identifying mutations in human tumors published online December 2 in The New England Journal of Medicine.

   
Released: 6-Dec-2021 12:30 PM EST
Childhood Cancer Survivors and Physical Activity
Rutgers Cancer Institute of New Jersey

Expert research at Rutgers Cancer Institute of New Jersey focuses on psychosocial aspects of pediatric, adolescent, and young adult cancer survivorship, including survivorship care and health promotion for survivors. Katie Devine, PhD, MPH, is section chief of Pediatric Population Science, Outcomes, and Disparities Research in the Division of Pediatric Hematology/Oncology at Rutgers Cancer Institute shares more.



close
0.4266